Clinical Trial Update: Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD) [NA]

View source ↗

Summary

This clinical trial, OMNeADHD, evaluates omega-3 fatty acids for Attention Deficit Hyperactivity Disorder in children/adolescents and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: China Medical University Hospital | Conditions: ADHD, Children | NA | Status: RECRUITING